Evidence Synthesis
AMBUJACEM experienced a standard shift on 2026-09-15, driven by accelerating metrics.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 15 Sept 2026, 00:11
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
AMBUJACEM experienced a standard shift on 2026-09-15, driven by accelerating metrics.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 56.82 % | 7.95 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 7.95 % | 11.13 | ▼ |
| REVENUE_GROWTH_YOY | -7.7 % | -27.5 | ▲ |
| EPS_ACTUAL | 8.052 INR | 0.954 | ▲ |
| EPS_SURPRISE_PERCENT | 1.111 % | -0.615 | ▲ |
| PRICE_CHANGE_PERCENT | -0.948 % | — | - |
| DAILY_VOLUME | 13,11,052 shares | 25,17,184 | ▼ |
| CLOSE_PRICE | 391.85 INR | 395.6 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.59 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 7 count | 19 | ▼ |
| TARGET_PRICE_PREMIUM | 25.03 % | — | - |